Summary
Gordon Findlay, an executive from Novo Nordisk, collapsed behind President Donald Trump during a press conference at the Oval Office. The event involved discussions with drugmakers about expanding and reducing prices for obesity treatments. The cause of his collapse is not yet known.
Key Facts
- Gordon Findlay is an executive at Novo Nordisk.
- He collapsed behind President Trump during a press conference.
- The press conference was held to discuss expanding coverage for obesity treatments Zepbound and Wegovy.
- Officials helped Findlay after he collapsed.
- The press was removed from the room soon after the incident.
- The reason for Findlay's collapse is currently unknown.
